News

Congress should prioritize affordability of medicines needed by Medicare beneficiaries suffering from diabetes and other chronic...

hese are not comfortable days in Washington for pharmacy benefit managers, the highly consolidated group of intermediaries that sit...

According to a 2021 Gallup poll, an estimated 18 million Americans can’t afford to pay for their much-needed prescription drugs. Across...

Legislation aimed at curbing several pharmacy benefit manager practices such as spread pricing cleared a key obstacle to passage in the...

The recent decision by the Federal Trade Commission to study the business practices of pharmacy benefit managers (PBMs) is a significant...

NCL is deeply concerned by the lack of transparency and accountability surrounding pharmacy benefit managers (PBMs). The pervasive power...

Nobody wants fraud — particularly not in medical care. Accordingly, in 1972, Congress passed the Federal Anti-kickback Statute that...

Agency to Scrutinize the Impact of Vertically Integrated Pharmacy Benefit Managers on the Access and Affordability of Medicine The...

Pharmacists play an essential role in the healthcare delivery system. Each day, their top priority is helping patients access medications...

The Executive Director of the PBM Accountability Project, Doug H. Dority, submitted public comment to the Federal Trade Commission (FTC)...

ICYMI | Grassley’s Leadership Recognized Multiple Times During Commerce Committee Hearing On Prescription Drug Pricing Reform WASHINGTON...

A U.S. Senate panel grilled secretive pharmacy benefit managers in a hearing Thursday on how to bring fairness and transparency to U.S....

Where are the mystery costs your pharmacy absorbs and how does it affect your drugs and price? Key stakeholders share their expertise...

Our responsibility as a leader in the healthcare system is to bring forward actionable ideas, data and insights to help create a...

The rising cost of health care is a sore point for all consumers and nowhere is it more glaring than at the pharmacy counter. However,...

U.S. Sen. Raphael Warnock just introduced a bill that would cap Americans’ out-of-pocket spending on insulin at $35 a month. The...

The Federal Trade Commission recently requested public comments on the effect of drug-industry middlemen on drug affordability and...

“Among other provisions, this bill would direct the Federal Trade Commission (FTC) to launch a study and report to Congress on the...

U.S. Sen. Ron Wyden (D-OR) is urging the Centers for Medicare and Medicaid Services (CMS) to finalize the proposal that applies all...

Too many people go to the pharmacy counter only to be told the cost of their prescription medicine has gone up. Again. It’s maddening at...

Following the Federal Trade Commission’s decision to not, at least initially, dig deeper into pharma middlemen known as PBMs, the...

Pharmacy benefit managers — liaisons between pharmaceutical companies and health insurers that run patients’ prescription benefits — are...

In the last 4 years, the three biggest pharmacy benefit managers have consolidated influence in the U.S. health care marketplace through...